[Form 4] Labcorp Holdings Inc. Insider Trading Activity

Filing Impact

(Moderate)

Filing Sentiment

(Negative)

Form Type

Rhea-AI Filing Summary

Yunhong Green CTI Ltd. (YHGJ) will hold its 2025 Annual Meeting on 22-Aug-25. Shareholders of record 23-Jul-25 will vote on:

Director election: five nominees (Schwan, Li, Bryant, Roberts, Wong) for one-year terms.
1-for-10 reverse stock split: would cut the 27.74 m outstanding shares to c.2.77 m. Purpose is to regain compliance with Nasdaq鈥檚 US$1.00 minimum bid price before the 19-Oct-25 grace-period deadline. Authorised share count and par value stay unchanged.
Auditor ratification: Wolf & Company, PC for FY-26; FY-24 audit fees US$629.5k after replacing disqualified firm BF Borgers.
Other routine business.

Insider ownership is high: Chairman Yubao Li holds 43.6 %; all insiders 44.8 %. Largest outside holders own 6.8-11 % each. Three directors are independent; Philip Wong serves as lead independent and audit-committee financial expert.

Compensation highlights: CEO Jana Schwan base salary US$275k plus 250 k-share performance RSU grant (222.8 k unvested). Independent directors receive US$12k cash and 5 k RSUs annually.

The Board recommends voting FOR all proposals; simple-majority approval required (director election by plurality).

鞙ろ檷攴鸽Π CTI Ltd. (YHGJ)電� 2025雲� 鞐半 欤检＜齑濏殞毳� 2025雲� 8鞗� 22鞚检棎臧滌禍頃╇媹雼�. 2025雲� 7鞗� 23鞚� 旮办 欤检＜霌れ潃雼れ潓鞎堦贝鞐� 雽€頃� 韴憸頃╇媹雼�:

鞚挫偓靹犾稖: 1雲� 鞛勱赴鞚� 雼れ劘頉勲炒鞛�(鞀堨檮, 毽�, 敫岆澕鞚挫柛韸�, 搿滊矂旄�, 鞗�).
1雽€ 10 鞎‰┐氤戫暕: 順勳灛 2,774毵� 欤茧ゼ鞎� 277毵� 欤茧 欷勳澊電� 鞎堦贝鞛呺媹雼�. 氇╈爜鞚€ 2025雲� 10鞗� 19鞚� 鞙犾槇旮瓣皠膦呺 鞝� 雮橃姢雼� 斓滌唽鞛呾鞍臧€ 1.00雼煬欷€靾橂ゼ須岆车頃橁赴鞙勴暔鞛呺媹雼�. 鞀轨澑霅� 氚滍枆欤检嫕靾橃檧鞎‰┐臧€電� 氤€瓴诫悩歆€ 鞎婌姷雼堧嫟.
臧愳偓鞚� 鞀轨澑: FY-26 須岅硠鞐半弰鞐� Wolf & Company, PC; FY-24 臧愳偓靾橃垬耄岆姅鞛愱博氚曧儓霅� BF Borgers毳� 雽€觳错暅頉� 62毵� 9500雼煬鞛呺媹雼�.
旮绊儉鞚检儊鞐呺.

雮措秬鞛� 歆€攵勳湪鞚� 雴掛姷雼堧嫟: 須岇灔鞙犽皵鞓� 毽皜 43.6% 氤挫湢; 氇摖雮措秬鞛� 歆€攵勳湪鞚€ 44.8%鞛呺媹雼�. 斓滊寑鞕鸽秬欤检＜霌れ潃臧侁皝 6.8~11%毳� 氤挫湢頃╇媹雼�. 靹� 氇呾潣鞚挫偓電� 霃呺 鞚挫偓鞚措┌, 頃勲 鞗§潃靾橃劃霃呺 鞚挫偓鞚挫瀽臧愳偓鞙勳洂須� 鞛 鞝勲臧€搿� 頇滊彊頃╇媹雼�.

氤挫儊欤检殧雮挫毄: CEO 鞛愲倶鞀堨檮鞚� 旮半掣旮夓潃 27毵� 5觳� 雼煬鞚措┌, 25毵� 欤� 靹标臣旮半皹 RSU毳� 攵€鞐皼鞎橃姷雼堧嫟(22毵� 2800欤茧姅鞎勳 氩犾姢韺呺悩歆€ 鞎婌潓). 霃呺 鞚挫偓霌れ潃鞐瓣皠 1毵� 2觳� 雼煬順勱笀瓿� 5觳� RSU毳� 氚涭姷雼堧嫟.

鞚挫偓須岆姅氇摖鞎堦贝鞐� 雽€頃� 彀劚韴憸毳� 甓岅碃頃橂┌, 鞀轨澑鞐愲姅雼垳瓿茧皹靾橁皜頃勳殧頃╇媹雼�(鞚挫偓靹犾稖鞚€ 雼れ垬霌濏憸鞝�).

Insights

TL;DR: Reverse split critical for Nasdaq bid-price compliance; corporate actions otherwise routine.

The proxy centres on a 1-for-10 split aimed at avoiding delisting after two grace periods. If executed, float shrinks to roughly 2.77 m shares, which should mechanically lift the price but may further reduce liquidity. High insider control (鈮�45 %) limits governance leverage for minority holders. Audit change to Wolf after BF Borgers鈥� disqualification raised audit fees ~76 %. No financial guidance or operational updates are provided; impact therefore revolves chiefly around market-access risk.

TL;DR: Governance framework adequate; concentration and split pose minority-holder concerns.

Board structure meets Nasdaq independence tests (3/5 independent, lead director, active committees). Yet the Chairman鈥檚 43.6 % stake plus insider bloc at 44.8 % effectively controls outcomes, rendering shareholder votes largely symbolic. Reverse split preserves listing but may dilute perceived value without addressing core performance issues. Auditor transition appears proper, but the large fee increase suggests elevated complexity. Overall governance posture is acceptable but not robustly shareholder-centric.

鞚挫偓靹犾稖: 1雲� 鞛勱赴鞚� 雼れ劘頉勲炒鞛�(鞀堨檮, 毽�, 敫岆澕鞚挫柛韸�, 搿滊矂旄�, 鞗�).
1雽€ 10 鞎‰┐氤戫暕: 順勳灛 2,774毵� 欤茧ゼ鞎� 277毵� 欤茧 欷勳澊電� 鞎堦贝鞛呺媹雼�. 氇╈爜鞚€ 2025雲� 10鞗� 19鞚� 鞙犾槇旮瓣皠膦呺 鞝� 雮橃姢雼� 斓滌唽鞛呾鞍臧€ 1.00雼煬欷€靾橂ゼ須岆车頃橁赴鞙勴暔鞛呺媹雼�. 鞀轨澑霅� 氚滍枆欤检嫕靾橃檧鞎‰┐臧€電� 氤€瓴诫悩歆€ 鞎婌姷雼堧嫟.
臧愳偓鞚� 鞀轨澑: FY-26 須岅硠鞐半弰鞐� Wolf & Company, PC; FY-24 臧愳偓靾橃垬耄岆姅鞛愱博氚曧儓霅� BF Borgers毳� 雽€觳错暅頉� 62毵� 9500雼煬鞛呺媹雼�.
旮绊儉鞚检儊鞐呺.

07/28/2025 - 03:59 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

ANDERSON KERRII B

(Last)

(First)

(Middle)

531 SOUTH SPRING STREET

(Street)

BURLINGTON

27215

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
LABCORP HOLDINGS INC. [ LH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/24/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	07/24/2025		S⁽¹⁾		3,500	D	$280	8,666	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

	/s/ Sandra D. van der Vaart, Attorney-in-Fact for Kerrii B. Anderson	07/28/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source:

AG真人官方